Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 101 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $209,000 | -0.5% | 14,400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $210,000 | +22.1% | 14,400 | 0.0% | 0.00% | – |
| Q1 2022 | $172,000 | -22.2% | 14,400 | +9.9% | 0.00% | -100.0% |
| Q4 2021 | $221,000 | -37.7% | 13,100 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $355,000 | -17.4% | 12,700 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $430,000 | +14.4% | 12,700 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $376,000 | -41.2% | 12,700 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $640,000 | +18.7% | 12,700 | -4.5% | 0.00% | 0.0% |
| Q3 2020 | $539,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,194,278 | $84,238,000 | 6.25% |
| Burrage Capital Management LLC | 123,025 | $4,723,000 | 3.73% |
| MPM BioImpact LLC | 337,291 | $12,949,000 | 3.12% |
| First Light Asset Management, LLC | 608,193 | $23,349,000 | 2.39% |
| Cormorant Asset Management, LP | 1,397,700 | $53,658,000 | 2.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 396,521 | $15,222,000 | 1.50% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 801 | $33,000 | 0.61% |
| Artal Group S.A. | 285,028 | $10,942,000 | 0.27% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 298,213 | $11,448,000 | 0.24% |
| Virtus ETF Advisers LLC | 7,309 | $281,000 | 0.15% |